Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 6Mucosal Melanoma 1

Interventions

camrelizumab 1apatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mucosal Melanoma × camrelizumab × Dermatologic × Clear all
NCT03986515 2019-06-14

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Henan Cancer Hospital

Phase 2 Unknown
40 enrolled
Dermatologic

Mucosal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡